A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG

This study has been completed.
Information provided by Medicure

Please refer to this study by its ClinicalTrials.gov identifier: NCT00402506

Locations


United States, North Carolina
	Duke Clinical Research Institute
	Durham, North Carolina, United States, 27705

Canada, Quebec
	Montreal Heart Institute
	Montreal, Quebec, Canada, H1T 1C8

Sponsors and Collaborators

Medicure

Investigators


Principal Investigator:	Michel Carrier, MD	Montreal Heart Institute

Principal Investigator:	Robert A Harrington, MD	Duke University